InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

- Current share price for OCC : $0.695

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$189 Orthocell Receives Approval for Human Hip Study Using Celgro 4 May 2016 9:08AM $0.415 $0.695 risen by 67.47%
$189 Orthocell receives R&D tax incentive refund 2 May 2016 9:31AM $0.420 $0.695 risen by 65.48%
$189 Appendix 4C - quarterly 29 Apr 2016 6:41PM $0.420 $0.695 risen by 65.48%
$189 Cell Factory Concept Further Validated in Leading Journal 20 Apr 2016 2:24PM $0.390 $0.695 risen by 78.21%
$189 Investor Presentation 28th Annual ROTH Conference 15 Mar 2016 8:17PM $0.370 $0.695 risen by 87.84%
$189 Change of Director's Interest Notice SW 4 Mar 2016 4:41PM $0.390 $0.695 risen by 78.21%
$189 Change of Director's Interest Notice PA 4 Mar 2016 4:40PM $0.390 $0.695 risen by 78.21%
$189 Change of Director's Interest Notice LL 4 Mar 2016 4:39PM $0.390 $0.695 risen by 78.21%
$189 Change of Director's Interest Notice QZ 4 Mar 2016 4:38PM $0.390 $0.695 risen by 78.21%
$189 Professor Rocky Tuan Appointed to Orthocell Advisory Board 4 Mar 2016 8:24AM $0.390 $0.695 risen by 78.21%
$189 Appendix 3B 26 Feb 2016 7:33PM $0.365 $0.695 risen by 90.41%
$189 Half Yearly Report and Accounts 26 Feb 2016 8:02AM $0.375 $0.695 risen by 85.33%
$189 Appendix 4C - quarterly 29 Jan 2016 4:29PM $0.515 $0.695 risen by 34.95%
$189 Results of Meeting 27 Jan 2016 7:59PM $0.540 $0.695 risen by 28.70%
$189 Tendon Data Presented at International Hip Conference 21 Jan 2016 9:18AM $0.550 $0.695 risen by 26.36%
$189 Orthocells Cell Factory Granted Patent in US 5 Jan 2016 9:55AM $0.395 $0.695 risen by 75.95%
$189 Notice of General Meeting/Proxy Form 22 Dec 2015 8:05PM $0.370 $0.695 risen by 87.84%
$189 Approval for Human Tendon Study Using Celgro Received 16 Dec 2015 9:44AM $0.355 $0.695 risen by 95.77%
$189 Orthocell Key Scaffold Patent Granted in Canada 9 Dec 2015 9:06AM $0.360 $0.695 risen by 93.06%
$189 Investor Presentation 30 Nov 2015 3:15PM $0.400 $0.695 risen by 73.75%
$189 Results of Meeting 27 Nov 2015 7:03PM $0.470 $0.695 risen by 47.87%
$189 Change in substantial holding SRV 25 Nov 2015 7:07PM $0.455 $0.695 risen by 52.75%
$189 Change in substantial holding MC 25 Nov 2015 7:06PM $0.455 $0.695 risen by 52.75%
$189 Orthocell Key Patents Granted for Celgro and Ortho-ATI 25 Nov 2015 9:32AM $0.460 $0.695 risen by 51.09%
$189 Becoming a substantial holder 23 Nov 2015 2:48PM $0.465 $0.695 risen by 49.46%

701 - 725 of 771 results

Page 29 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.